Announcements Trials

Browse Landscape

Phase

Phase 2 16 Phase NA 6 Phase 1 3 Phase 3 2 Phase 1/2 2 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 36 INDUSTRY 15 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Lymphoma 4 Colorectal Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Xerostomia 1 Warts 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Tongue Neoplasms 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma 1 Stomach Neoplasms 1 Sezary Syndrome 1 Seminoma 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Previously Treated Non-Small Cell Lung Cancer 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Pain 1

Interventions

Oxaliplatin 1 Leucovorin 1 Gastrectomy 1 Fluorouracil 1 Epirubicin 1 Docetaxel 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NETWORK × Stomach Neoplasms × Clear all

NCT01924819 2025-03-04

TOPGEAR

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡